Hydroxyzine

Hydroxyzine is a diphenylmethylpiperazine, a first-generation (sedating) antihistamine developed in the 1950s and among the earliest antihistamines brought to market; it was first made by Union Chimique Belge in the mid-1950s and introduced in the United States by Pfizer shortly after. It is available as two salts, the hydrochloride (marketed as Atarax) and the pamoate (marketed as Vistaril), given by mouth or by intramuscular injection. Unlike newer non-sedating antihistamines, hydroxyzine crosses the blood-brain barrier easily, which gives it calming and sleep-inducing properties alongside its antiallergic action ^[3].

Clinically hydroxyzine is used across several areas. As an antihistamine it relieves itching and the wheals of chronic urticaria and other allergic skin conditions, and it is used for nausea and as a sedative. In psychiatry it is prescribed as an anxiolytic for generalized anxiety disorder and for short-term situational anxiety, valued partly because, unlike benzodiazepines, it is not habit-forming. A Cochrane systematic review found hydroxyzine more effective than placebo for generalized anxiety disorder and broadly comparable to benzodiazepines and buspirone, while cautioning that the supporting trials were small and at risk of bias, so it is not established as a reliable first-line choice ^[1]. Reviews of anxiety pharmacotherapy accordingly list it among the antihistamine options for the disorder ^[2]. It is also widely used as a premedication before anesthesia and to strengthen the effect of opioid painkillers.

Hydroxyzine is a prescription medicine available as tablets, capsules, oral syrup and solution for injection. It is generally considered non-addictive, but its sedating nature brings drowsiness, dry mouth and headache, and, like a number of older antihistamines, it can prolong the heart's QT interval, so caution is advised in people with cardiac risk factors and it is often avoided in the elderly. In the body, hydroxyzine is metabolized to cetirizine, its carboxylated derivative, which keeps strong H1-blocking activity but causes much less sedation and is itself marketed as a second-generation antihistamine ^[3].

Hydroxyzine is prescription only. The most common effects are drowsiness, dry mouth, and a hungover or foggy feeling the next morning; some people feel dizzy or unsteady. Anticholinergic load makes it a poor choice for older adults, who face confusion, urinary retention, and fall risk, and it should be avoided in narrow-angle glaucoma and significant prostate enlargement. Regulators have flagged dose-dependent QT prolongation, so it is used cautiously in people with heart rhythm problems or on other QT-prolonging drugs. It adds to the sedation of alcohol, opioids, benzodiazepines, and other depressants. It is generally avoided in early pregnancy.

Hydroxyzine was synthesized in 1956 by the Belgian firm Union Chimique Belge, part of the first generation of piperazine antihistamines developed as the antihistamine field expanded in the postwar years. It was brought to market by Pfizer under the brand names Atarax and, as the pamoate salt, Vistaril, and quickly found a dual role: relieving allergic itching and hives while also serving as a sedating anti-anxiety agent and pre-operative calmative.

Because it reliably produced drowsiness and calm without the dependence of barbiturates or benzodiazepines, it became a durable option in both allergy and psychiatry. Decades later, researchers established that the body metabolizes hydroxyzine into cetirizine, which Union Chimique Belge went on to develop and launch as a leading non-sedating second-generation antihistamine. Hydroxyzine thus occupies an unusual place in pharmacology as both an enduring medicine in its own right and the metabolic parent of a blockbuster successor.

Hydroxyzine is well regarded as a dependable, non-addictive option for anxiety and for itching, and its long track record gives prescribers confidence. Many patients and clinicians value that, unlike benzodiazepines, it carries no risk of dependence or withdrawal, which has made it attractive as short-term anxiety relief and as an as-needed calmative. Its calming effect tends to come on relatively quickly, and it doubles usefully as an antihistamine for hives and as a premedication before procedures. The honest trade-off is sedation and dry mouth, and at higher doses attention to the QT interval is warranted because of its effect on cardiac potassium channels. It is generally seen as a solid, versatile workhorse rather than a first-line antidepressant-class treatment for chronic anxiety, but within that role its safety profile is a genuine strength.